{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:10:18Z","timestamp":1792098618405,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071785;31670925"],"award-info":[{"award-number":["82071785;31670925"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Aberrant RNA splicing in keratinocytes drives inflammatory skin disorders. In the present study, we found that the RNA helicase DDX5 was downregulated in keratinocytes from the inflammatory skin lesions in patients with atopic dermatitis and psoriasis, and that mice with keratinocyte-specific deletion of\n                    <jats:italic>Ddx5<\/jats:italic>\n                    (\n                    <jats:italic>Ddx5<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2206KC<\/jats:italic>\n                    <\/jats:sup>\n                    ) were more susceptible to cutaneous inflammation. Inhibition of DDX5 expression in keratinocytes was induced by the cytokine interleukin (IL)-17D through activation of the CD93\u2013p38 MAPK\u2013AKT\u2013SMAD2\/3 signaling pathway and led to pre-messenger RNA splicing events that favored the production of membrane-bound, intact IL-36 receptor (IL-36R) at the expense of soluble IL-36R (sIL-36R) and to the selective amplification of IL-36R-mediated inflammatory responses and cutaneous inflammation. Restoration of sIL-36R in\n                    <jats:italic>Ddx5<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2206KC<\/jats:italic>\n                    <\/jats:sup>\n                    mice with experimental atopic dermatitis or psoriasis suppressed skin inflammation and alleviated the disease phenotypes. These findings indicate that IL-17D modulation of DDX5 expression controls inflammation in keratinocytes during inflammatory skin diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41590-022-01339-3","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T12:19:16Z","timestamp":1666354756000},"page":"1577-1587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8786-3460","authenticated-orcid":false,"given":"Xinhui","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9297-095X","authenticated-orcid":false,"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5549-2706","authenticated-orcid":false,"given":"Wang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6912-0463","authenticated-orcid":false,"given":"Baida","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7851-7064","authenticated-orcid":false,"given":"Jian","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7341-9780","authenticated-orcid":false,"given":"Xinxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8618-9128","authenticated-orcid":false,"given":"Xiaoguang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1545-8087","authenticated-orcid":false,"given":"Hongquan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0997-6424","authenticated-orcid":false,"given":"Lian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6393-1986","authenticated-orcid":false,"given":"Zeyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1186-8609","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieliu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Fa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0084-9130","authenticated-orcid":false,"given":"Chen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7445-6738","authenticated-orcid":false,"given":"Yuping","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"1339_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41577-019-0195-7","volume":"19","author":"L Frankiw","year":"2019","unstructured":"Frankiw, L., Baltimore, D. & Li, G. D. Alternative mRNA splicing in cancer immunotherapy. Nat. Rev. Immunol. 19, 675\u2013687 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1339_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tig.2018.10.002","volume":"35","author":"M Montes","year":"2019","unstructured":"Montes, M., Sanford, B. L., Comiskey, D. F. & Chandler, D. S. RNA splicing and disease: animal models to therapies. Trends Genet. 35, 68\u201387 (2019).","journal-title":"Trends Genet."},{"key":"1339_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/intimm\/dxx026","volume":"29","author":"A Schaub","year":"2017","unstructured":"Schaub, A. & Glasmacher, E. Splicing in immune cells-mechanistic insights and emerging topics. Int. Immunol. 29, 173\u2013181 (2017).","journal-title":"Int. Immunol."},{"key":"1339_CR4","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jaci.2011.01.053","volume":"127","author":"E Guttman-Yassky","year":"2011","unstructured":"Guttman-Yassky, E., Nograles, K. E. & Krueger, J. G. Contrasting pathogenesis of atopic dermatitis and psoriasis\u2013part I: clinical and pathologic concepts. J. Allergy Clin. Immunol. 127, 1110\u20131118 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1339_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coi.2017.08.008","volume":"48","author":"E Guttman-Yassky","year":"2017","unstructured":"Guttman-Yassky, E. & Krueger, J. G. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? Curr. Opin. Immunol. 48, 68\u201373 (2017).","journal-title":"Curr. Opin. Immunol."},{"key":"1339_CR6","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.jid.2018.12.018","volume":"139","author":"LC Tsoi","year":"2019","unstructured":"Tsoi, L. C. et al. Atopic dermatitis Is an IL-13-dominant disease with greater molecular heterogeneity compared to psoriasis. J. Invest. Dermatol. 139, 1480\u20131489 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"1339_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22284-y","volume":"8","author":"J Li","year":"2018","unstructured":"Li, J. & Yu, P. Genome-wide transcriptome analysis identifies alternative splicing regulatory network and key splicing factors in mouse and human psoriasis. Sci. Rep. 8, 4124 (2018).","journal-title":"Sci. Rep."},{"key":"1339_CR8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/ijms21030699","volume":"21","author":"J Schwingen","year":"2020","unstructured":"Schwingen, J., Kaplan, M. & Kurschus, F. C. Review\u2014current concepts in inflammatory skin diseases evolved by transcriptome analysis: in depth analysis of atopic dermatitis and psoriasis. Int. J. Mol. Sci. 21, 699 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1339_CR9","doi-asserted-by":"publisher","first-page":"e1519","DOI":"10.1002\/wrna.1519","volume":"10","author":"Z Xing","year":"2019","unstructured":"Xing, Z., Ma, W. K. & Tran, E. J. The DDX5\/Dbp2 subfamily of DEAD-box RNA helicases. Wiley Interdiscip. Rev. RNA 10, e1519 (2019).","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"1339_CR10","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1002\/jcp.26912","volume":"234","author":"V Hashemi","year":"2019","unstructured":"Hashemi, V. et al. The role of DEAD-box RNA helicase p68 (DDX5) in the development and treatment of breast cancer. J. Cell Physiol. 234, 5478\u20135487 (2019).","journal-title":"J. Cell Physiol."},{"key":"1339_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09972-7","volume":"10","author":"JMD Legrand","year":"2019","unstructured":"Legrand, J. M. D. et al. DDX5 plays essential transcriptional and post-transcriptional roles in the maintenance and function of spermatogonia. Nat. Commun. 10, 2278 (2019).","journal-title":"Nat. Commun."},{"key":"1339_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4161\/rna.23312","volume":"10","author":"FV Fuller-Pace","year":"2013","unstructured":"Fuller-Pace, F. V. DEAD box RNA helicase functions in cancer. RNA Biol. 10, 121\u2013132 (2013).","journal-title":"RNA Biol."},{"key":"1339_CR13","doi-asserted-by":"publisher","first-page":"e1009530","DOI":"10.1371\/journal.ppat.1009530","volume":"17","author":"J Xu","year":"2021","unstructured":"Xu, J. et al. The RNA helicase DDX5 promotes viral infection via regulating N6-methyladenosine levels on the DHX58 and NFkappaB transcripts to dampen antiviral innate immunity. PLoS Pathog. 17, e1009530 (2021).","journal-title":"PLoS Pathog."},{"key":"1339_CR14","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1016\/j.jid.2016.07.008","volume":"136","author":"X Xing","year":"2016","unstructured":"Xing, X. et al. IL-17 responses a the dominant inflammatory signal linking inverse, erythrodermic, and chronic plaque psoriasis. J. Invest Dermatol. 136, 2498\u20132501 (2016).","journal-title":"J. Invest Dermatol."},{"key":"1339_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15649-3","volume":"11","author":"Y Han","year":"2020","unstructured":"Han, Y. et al. Genome-wide analysis highlights contribution of immune system pathways to the genetic architecture of asthma. Nat. Commun. 11, 1776 (2020).","journal-title":"Nat. Commun."},{"key":"1339_CR16","unstructured":"Bantz, S.K., Zhu, Z. & Zheng, T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J. Clin. Cell Immunol. 5, 202 (2014)."},{"key":"1339_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.immuni.2012.04.010","volume":"37","author":"Y Lai","year":"2012","unstructured":"Lai, Y. et al. The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury. Immunity 37, 74\u201384 (2012).","journal-title":"Immunity"},{"key":"1339_CR18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.immuni.2018.03.019","volume":"48","author":"M Xu","year":"2018","unstructured":"Xu, M. et al. An interleukin-25-mediated autoregulatory circuit in keratinocytes plays a pivotal role in psoriatic skin inflammation. Immunity 48, 787\u2013798 e784 (2018).","journal-title":"Immunity"},{"key":"1339_CR19","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"MJ McGeachy","year":"2019","unstructured":"McGeachy, M. J., Cua, D. J. & Gaffen, S. L. The IL-17 family of cytokines in health and disease. Immunity 50, 892\u2013906 (2019).","journal-title":"Immunity"},{"key":"1339_CR20","doi-asserted-by":"publisher","unstructured":"Su, Y. et al. Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation. Sci. Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aau9657 (2019).","DOI":"10.1126\/sciimmunol.aau9657"},{"key":"1339_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/jid.2010.277","volume":"131","author":"M Hvid","year":"2011","unstructured":"Hvid, M. et al. IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J. Invest. Dermatol. 131, 150\u2013157 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"1339_CR22","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/intimm\/dxab075","volume":"33","author":"SH Chung","year":"2021","unstructured":"Chung, S. H., Ye, X. Q. & Iwakura, Y. Interleukin-17 family members in health and disease. Int. Immunol. 33, 723\u2013729 (2021).","journal-title":"Int. Immunol."},{"key":"1339_CR23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.immuni.2021.03.018","volume":"54","author":"J Huang","year":"2021","unstructured":"Huang, J. et al. Interleukin-17D regulates group 3 innate lymphoid cell function through its receptor CD93. Immunity 54, 673\u2013686 e674 (2021).","journal-title":"Immunity"},{"key":"1339_CR24","doi-asserted-by":"publisher","first-page":"eaba6500","DOI":"10.1126\/science.aba6500","volume":"371","author":"G Reynolds","year":"2021","unstructured":"Reynolds, G. et al. Developmental cell programs are co-opted in inflammatory skin disease. Science 371, eaba6500 (2021).","journal-title":"Science"},{"key":"1339_CR25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan, S. M., Irvine, A. D. & Weidinger, S. Atopic dermatitis. Lancet 396, 345\u2013360 (2020).","journal-title":"Lancet"},{"key":"1339_CR26","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","volume":"201","author":"JE Hawkes","year":"2018","unstructured":"Hawkes, J. E., Yan, B. Y., Chan, T. C. & Krueger, J. G. Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis. J. Immunol. 201, 1605\u20131613 (2018).","journal-title":"J. Immunol."},{"key":"1339_CR27","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jaci.2015.08.015","volume":"136","author":"S Noda","year":"2015","unstructured":"Noda, S. et al. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. J. Allergy Clin. Immunol. 136, 1254\u20131264 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1339_CR28","doi-asserted-by":"crossref","unstructured":"Shao, S. et al. IRAK2 has a critical role in promoting feed-forward amplification of epidermal inflammatory responses. J. Invest. Dermatol. 141, 2436\u20132448 (2021).","DOI":"10.1016\/j.jid.2021.03.019"},{"key":"1339_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nm804","volume":"9","author":"K Ghoreschi","year":"2003","unstructured":"Ghoreschi, K. et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat. Med. 9, 40\u201346 (2003).","journal-title":"Nat. Med."},{"key":"1339_CR30","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jaci.2009.07.004","volume":"124","author":"E Gros","year":"2009","unstructured":"Gros, E., Bussmann, C., Bieber, T., Forster, I. & Novak, N. Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis. J. Allergy Clin. Immunol. 124, 753\u2013760.e751 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1339_CR31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes, M. A., Suarez-Farinas, M. & Krueger, J. G. Immunology of psoriasis. Annu Rev. Immunol. 32, 227\u2013255 (2014).","journal-title":"Annu Rev. Immunol."},{"key":"1339_CR32","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1101\/gad.316034.118","volume":"32","author":"YJ Lee","year":"2018","unstructured":"Lee, Y. J., Wang, Q. & Rio, D. C. Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5. Genes Dev. 32, 1060\u20131074 (2018).","journal-title":"Genes Dev."},{"key":"1339_CR33","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1128\/MCB.01117-10","volume":"31","author":"J Han","year":"2011","unstructured":"Han, J. et al. SR proteins induce alternative exon skipping through their activities on the flanking constitutive exons. Mol. Cell. Biol. 31, 793\u2013802 (2011).","journal-title":"Mol. Cell. Biol."},{"key":"1339_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0092-8674(90)90237-9","volume":"62","author":"AR Krainer","year":"1990","unstructured":"Krainer, A. R., Conway, G. C. & Kozak, D. The essential pre-mRNA splicing factor SF2 influences 5\u2032 splice site selection by activating proximal sites. Cell 62, 35\u201342 (1990).","journal-title":"Cell"},{"key":"1339_CR35","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1093\/emboj\/17.22.6747","volume":"17","author":"BR Graveley","year":"1998","unstructured":"Graveley, B. R., Hertel, K. J. & Maniatis, T. A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers. EMBO J. 17, 6747\u20136756 (1998).","journal-title":"EMBO J."},{"key":"1339_CR36","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.celrep.2014.03.073","volume":"7","author":"T O\u2019Sullivan","year":"2014","unstructured":"O\u2019Sullivan, T. et al. Interleukin-17D mediates tumor rejection through recruitment of natural killer cells. Cell Rep. 7, 989\u2013998 (2014).","journal-title":"Cell Rep."},{"key":"1339_CR37","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3389\/fimmu.2019.01172","volume":"10","author":"Y Lee","year":"2019","unstructured":"Lee, Y., Clinton, J., Yao, C. & Chang, S. H. Interleukin-17D promotes pathogenicity during infection by suppressing CD8 T cell activity. Front. Immunol. 10, 1172 (2019).","journal-title":"Front. Immunol."},{"key":"1339_CR38","doi-asserted-by":"publisher","first-page":"642","DOI":"10.4049\/jimmunol.169.2.642","volume":"169","author":"T Starnes","year":"2002","unstructured":"Starnes, T., Broxmeyer, H. E., Robertson, M. J. & Hromas, R. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J. Immunol. 169, 642\u2013646 (2002).","journal-title":"J. Immunol."},{"key":"1339_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-biochem-060614-034316","volume":"84","author":"Y Lee","year":"2015","unstructured":"Lee, Y. & Rio, D. C. Mechanisms and regulation of alternative pre-mRNA splicing. Annu. Rev. Biochem. 84, 291\u2013323 (2015).","journal-title":"Annu. Rev. Biochem."},{"key":"1339_CR40","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0968-0004(96)10039-6","volume":"21","author":"J Valcarcel","year":"1996","unstructured":"Valcarcel, J. & Green, M. R. The SR protein family: pleiotropic functions in pre-mRNA splicing. Trends Biochem. Sci. 21, 296\u2013301 (1996).","journal-title":"Trends Biochem. Sci."},{"key":"1339_CR41","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1261\/rna.2269306","volume":"12","author":"S Spena","year":"2006","unstructured":"Spena, S., Tenchini, M. L. & Buratti, E. Cryptic splice site usage in exon 7 of the human fibrinogen Bbeta-chain gene is regulated by a naturally silent SF2\/ASF binding site within this exon. RNA 12, 948\u2013958 (2006).","journal-title":"RNA"},{"key":"1339_CR42","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00439-016-1683-5","volume":"135","author":"T Geuens","year":"2016","unstructured":"Geuens, T., Bouhy, D. & Timmerman, V. The hnRNP family: insights into their role in health and disease. Hum. Genet. 135, 851\u2013867 (2016).","journal-title":"Hum. Genet."},{"key":"1339_CR43","doi-asserted-by":"publisher","first-page":"155897","DOI":"10.1016\/j.cyto.2022.155897","volume":"156","author":"KL Sachen","year":"2022","unstructured":"Sachen, K. L., Arnold Greving, C. N. & Towne, J. E. Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions. Cytokine 156, 155897 (2022).","journal-title":"Cytokine"},{"key":"1339_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-020-00937-1","volume":"20","author":"MS Tsang","year":"2020","unstructured":"Tsang, M. S., Sun, X. & Wong, C. K. The role of new IL-1 family members (IL-36 and IL-38) in atopic dermatitis, allergic asthma, and allergic rhinitis. Curr. Allergy Asthma Rep. 20, 40 (2020).","journal-title":"Curr. Allergy Asthma Rep."},{"key":"1339_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/JLB.5MR0120-439R","volume":"108","author":"X Ni","year":"2020","unstructured":"Ni, X. & Lai, Y. Keratinocyte: a trigger or an executor of psoriasis? J. Leukoc. Biol. 108, 485\u2013491 (2020).","journal-title":"J. Leukoc. Biol."},{"key":"1339_CR46","doi-asserted-by":"publisher","first-page":"e143334","DOI":"10.1172\/JCI143334","volume":"131","author":"GJ Patrick","year":"2021","unstructured":"Patrick, G. J. et al. Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease. J. Clin. Invest. 131, e143334 (2021).","journal-title":"J. Clin. Invest."},{"key":"1339_CR47","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1016\/j.jid.2017.07.820","volume":"137","author":"Z Jiang","year":"2017","unstructured":"Jiang, Z. et al. IL-36gamma Induced by the TLR3-SLUG-VDR axis promotes wound healing via REG3A. J. Invest. Dermatol. 137, 2620\u20132629 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"1339_CR48","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1172\/JCI63451","volume":"122","author":"L Tortola","year":"2012","unstructured":"Tortola, L. et al. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J. Clin. Invest. 122, 3965\u20133976 (2012).","journal-title":"J. Clin. Invest."},{"key":"1339_CR49","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/imr.12610","volume":"281","author":"EY Bassoy","year":"2018","unstructured":"Bassoy, E. Y., Towne, J. E. & Gabay, C. Regulation and function of interleukin-36 cytokines. Immunol. Rev. 281, 169\u2013178 (2018).","journal-title":"Immunol. Rev."},{"key":"1339_CR50","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi, S. et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N. Engl. J. Med. 365, 620\u2013628 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1339_CR51","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"1339_CR52","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357\u2013360 (2015).","journal-title":"Nat. Methods"},{"key":"1339_CR53","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"1339_CR54","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"1339_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1339_CR56","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"1339_CR57","doi-asserted-by":"publisher","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","volume":"111","author":"S Shen","year":"2014","unstructured":"Shen, S. et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc. Natl Acad. Sci. USA 111, E5593\u2013E5601 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1339_CR58","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","volume":"35","author":"Y Cai","year":"2011","unstructured":"Cai, Y. et al. Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 35, 596\u2013610 (2011).","journal-title":"Immunity"},{"key":"1339_CR59","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nprot.2006.47","volume":"1","author":"JD Keene","year":"2006","unstructured":"Keene, J. D., Komisarow, J. M. & Friedersdorf, M. B. RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nat. Protoc. 1, 302\u2013307 (2006).","journal-title":"Nat. Protoc."},{"key":"1339_CR60","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma, J. et al. iProX: an integrated proteome resource. Nucleic Acids Res. 47, D1211\u2013D1217 (2019).","journal-title":"Nucleic Acids Res."}],"updated-by":[{"DOI":"10.1038\/s41590-026-02636-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000}}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01339-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01339-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01339-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:02:26Z","timestamp":1787036546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01339-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1339"],"URL":"https:\/\/doi.org\/10.1038\/s41590-022-01339-3","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"12 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41590-026-02636-x","URL":"https:\/\/doi.org\/10.1038\/s41590-026-02636-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.L., X.N., Y.X., W.W., Y.W., B.K. and X.G. have filed provisional patents (202110117195.8 and 201910333393.0) disclosure based on the results in the paper. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}